Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Serono Serostim

Executive Summary

Counterfeit AIDS wasting treatment Serostim bears lot number MNH605A, Serono says. The company is sending letters to wholesale distributors, pharmacies, physicians and AIDS service organizations notifying them of the counterfeit product. Counterfeit Serostim was previously reported by 10 to 12 patients, primarily in California (1"The Pink Sheet" Jan. 29, p. 36)

You may also be interested in...



Genentech Nutropin AQ

Counterfeit of the human growth hormone labeled as Nutropin AQ 10 mg vials in 6-pack boxes reported by Genentech in May 22 letter to patients, physicians, pharmacies and wholesalers. For counterfeit lot L9504A2, the solution is cloudy at room temperature but clear when refrigerated, Genentech says, instead of consistently clear. Counterfeit of Serono's human growth hormone Serostim was also recently reported (1"The Pink Sheet" May 21, p. 28)

Genentech Nutropin AQ

Counterfeit of the human growth hormone labeled as Nutropin AQ 10 mg vials in 6-pack boxes reported by Genentech in May 22 letter to patients, physicians, pharmacies and wholesalers. For counterfeit lot L9504A2, the solution is cloudy at room temperature but clear when refrigerated, Genentech says, instead of consistently clear. Counterfeit of Serono's human growth hormone Serostim was also recently reported (1"The Pink Sheet" May 21, p. 28)

Serono Serostim

Counterfeit Serostim has been reported by 10 to 12 patients, primarily in California. The only reported adverse reaction by patients who had injected the counterfeit product was skin irritation at the injection site, the company said. FDA's Office of Criminal Investigations is attempting to determine the distributor of the fake product. Somatropin is approved for AIDS wasting

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037885

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel